Responsible use of antibiotics
At Syva, we strongly support the prudent use of antimicrobials in animals.
Bacterial diseases have to be treated effectively and efficiently.
Antimicrobials (antibiotics) are essential to cure bacterial diseases. Not only they cure, but they also prevent the further spread of the disease and the suffering of animals.
At Syva, we strongly believe that prevention is better than cure, but even with excellent management, animals still suffer from infectious bacterial diseases, and antimicrobial treatment is needed. We encourage vets to prescribe antimicrobials “as little as possible, as much as necessary” respecting responsible use principles.
Using antimicrobials in a responsible way contributes to maintain their efficacy in the future.
More on Social Responsibility
Animal welfare
Farm animals are essential to the society, providing food (milk, eggs, meat) to billions of people around the world. For this reason, farm animals deserve the highest standards of well-being.
Commitment to the environment
True to our values, we want to develop our activities while improving the conditions of occupational safety and with the minimum possible impact on the environment.
Our commitment to quality
We make no concessions in terms of quality. Our customers trust us for the quality of our products and services, which is guaranteed by strict internal controls and external audits.
Diversity and inclusion
Diversity and inclusion are powerful drivers of progress and growth. At Syva, we build an environment conducive to the development of our values of result orientation, trust, initiative and collaboration.
Connected to shared values
Syva is an active member of Veterindustria and AnimalhealthEurope, two associations in which it shares the common values of sustainable contribution to public and animal health.
You may also be interested in
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.
4 October, 2024
Vaccination against Bluetongue serotype 3 has started in Spain with Syvazul BTV3
Laboratorios Syva announces that the first doses of its Syvazul BTV3 vaccine have already arrived in Andalusia and Extremadura, allowing the vaccination programme against this new serotype to begin. In September 2024, outbreaks were detected in the south of Portugal, very close to the border with Spain, which set in motion the protocols for the prevention and control of...
30 August, 2023
New tool for controlling erysipelas and PPV: Syvac® Ery Parvo
Because every farm is unique, it needs individualised protocols for swine erysipela and PPV control. Failing to control erysipelas and PPV throughout a sow's life can lead to a host of problems that are difficult to control and have a direct impact on production.
Newsfeed
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
